Workflow
Adjusted Financial Measurements
icon
搜索文档
CONMED (CNMD) - 2025 Q2 - Earnings Call Presentation
2025-07-31 04:30
July 30, 2025 Investor Presentation Q2 2025 Earnings Pat J. Beyer President and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer Forward-Looking Information This presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward- looking statements herein or in previous disclosures. F ...
CONMED (CNMD) - 2025 Q1 - Earnings Call Presentation
2025-05-01 04:13
业绩总结 - 2025年第一季度全球收入为3.213亿美元,同比增长2.9%[25] - 调整后每股收益为0.95美元,同比增加20.1%[22] - GAAP每股收益为0.19美元,同比下降69.3%[22] - 国内收入为1.838亿美元,占总收入的57%[22] - 国际收入为1.375亿美元,占总收入的43%[22] 用户数据 - 骨科手术收入为1.383亿美元,增长3.9%[22] - 普通外科收入为1.830亿美元,增长3.8%[22] 未来展望 - 预计2025年报告收入范围为13.50亿至13.78亿美元,年增长约4%至6%[26] - 预计调整后每股收益为4.60至4.70美元,年增长约10%至13%[26] - 预计外汇影响将导致每股收益减少0.15至0.10美元[26]